MPO and triple-A syndrome: In summary, we conclude that neither D-dimer nor MPO plasma levels nor a combination of both or cell-free DNA plasma levels are suitable for use as biomarkers for the monitoring and/or prognostics of AAA in the real-world setting of a vascular surgery department.